Corporate calendar for InflaRx N.V. (IFRX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
InflaRx N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel inhibitors leveraging C5a technology, primarily operating in Germany and the United States. The company's focus on C5a stems from its critical role as an inflammatory mediator implicated in the progression of various autoimmune and inflammatory diseases.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $144M | |
| 2026-09-14 | $898M |
Price
| Price | $2.04 |
| Market Cap | $300M |
| Exchange | NASDAQ |
| Country | DE |
Related companies: ARTV · ATYR · CNTB · CNTX · IMA · KLRS · MGX
Explore sector: Healthcare · Biotechnology
More sections of IFRX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks